ScholarIQanswers from OpenAlex

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine

PaperCitations, authors & open-access status

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine have?

ScholarIQcitation count

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine has 67 citations in the OpenAlex counts ScholarIQ stores.

When was Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine published?

ScholarIQyear

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine has 2016 year in the ScholarIQ index.

What is the open-access status of Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine?

ScholarIQoa status

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine has diamond oa status in the ScholarIQ index.

What is the DOI of Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine?

ScholarIQdoi

The DOI for Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine is on the source record.

What is the PMID of Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine?

ScholarIQpmid

The PMID for Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine is on the source record.

What is the OpenAlex record for Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine?

ScholarIQopenalex

The OpenAlex for Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial